News Channels

06 Dec 2017 U.S. Food and Drug Administration Lifts Partial Clinical Holds on Two Opdivo-based Combination Studies in Multiple Myeloma
06 Dec 2017 Ozempic® (semaglutide) approved in the US
06 Dec 2017 First patient enrolled in Phase 3 trial for ATIR101™ in adult patients with blood cancer
06 Dec 2017 FDA Grants Genentech’s Avastin Full Approval for Most Aggressive Form of Brain Cancer
05 Dec 2017 Poseida Therapeutics Presents Preclinical Solid Tumor Data for P-PSMA-101 at the American Association for Cancer Research Prostate Cancer Meeting
05 Dec 2017 Galectin Therapeutics Announces Results from Phase 2b NASH-CX Trial
05 Dec 2017 100% of Prostate Cancer Patients Completing 31-Week Post-Therapy Exam After Treatment with OncBioMune Immunotherapy Show No Disease Progression
05 Dec 2017 Novan Announces First Patient Dosed in Phase 1b Atopic Dermatitis Trial with SB414
05 Dec 2017 CSL and Vitaeris Announce Strategic Partnership with Option to Acquire
05 Dec 2017 Adverum Biotechnologies Begins Patient Enrollment in the ADVANCE Phase 1/2 Clinical Trial for A1AT Deficiency
05 Dec 2017 IMBRUVICA® (ibrutinib) Plus Rituximab Phase 3 iNNOVATE Trial in Rare Waldenström's Macroglobulinemia Met Primary Endpoint
05 Dec 2017 Zymeworks Presents Results of the Completed Dose Escalation Portion of the Ongoing Phase 1 Study of ZW25 at the San Antonio Breast Cancer Symposium
05 Dec 2017 Revance’s RT002 Meets Primary and All Secondary Endpoints, Achieves 6-Month Duration in Pivotal SAKURA Phase 3 Trials for Glabellar Lines
05 Dec 2017 Realm Therapeutics Announces First Patient Dosed in Phase 2 Study of PR022 for the Treatment of Atopic Dermatitis
05 Dec 2017 Adamis Pharmaceuticals Announces Submission of Investigational New Drug (IND) Application to the FDA for New Product Candidate for the Treatment of Opioid Overdose
05 Dec 2017 ObsEva Initiates PROLONG, the Phase 2a Clinical Trial of OBE022 in Preterm Labor
05 Dec 2017 Immunovaccine Announces Positive Clinical Data from Its Collaborative Combination Immunotherapy Trial in Advanced Ovarian Cancer
05 Dec 2017 Led by OrbiMed Israel and Peter Thiel, ChemomAb Raises $10 Million in Series B Funding
05 Dec 2017 Idorsia announces collaboration with Janssen Biotech on aprocitentan (ACT-132577)
04 Dec 2017 Ironwood Reports Top-line Phase IIa Data for IW-1973 Demonstrating Positive Cardiovascular, Metabolic and Endothelial Effects

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top